private:novaresurgical
|
70166
|
May 30th, 2019 12:00AM
|
Novare Surgical Systems
|
634
|
7.00
|
Open
|
Medical Devices
|
May 30th, 2019 04:12PM
|
May 30th, 2019 04:12PM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
Open
|
Surgical Instruments
|
Open
|
|
|
|
US
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 17th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 16th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 15th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 14th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 13th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 12th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 11th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 10th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|
private:novaresurgical
|
70166
|
Feb 9th, 2018 12:00AM
|
Novare Surgical Systems
|
613
|
7.00
|
Open
|
Medical Devices
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets devices for minimally invasive surgery.
RealHand® High Dexterity (HD) Instruments were developed entirely at Novare Surgical and represent a shift in the company’s focus toward devices for minimally invasive surgery. First introduced and used clinically in 2006, RealHand HD instruments are the very first seven degree of freedom hand-held laparoscopic instruments. Developed with the EndoLink® mechanism, RealHand technology is designed to mirror the surgeon’s hand direction with the added benefit of tactile feedback. As such, when the surgeon’s hand moves in one direction, the instrument tip exactly follows. The invention of RealHand HD instruments has placed Novare at the forefront of emerging minimally invasive therapies such as single port surgery and natural orifice transluminal endoscopic surgery (NOTES) and the company is committed to the surgeons and patients who benefit from this advancement in instrumentation.
In the cardiac surgery arena, Novare developed the Enclose II Device, which is used in off pump coronary artery bypass surgery. The Enclose® II proximal anastomotic assist device was designed specifically to obviate the need for partial clamping of the aorta. The Enclose device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps.
|
|
|
|
|
|
|
|
|
|
Novare Surgical
|
|
Health Care Equipment & Services
|